Literature DB >> 10084530

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

C Liu1, S Edwards, Q Gong, N Roberts, L D Blumhardt.   

Abstract

OBJECTIVE: The association between brain atrophy and permanent functional deficits in multiple sclerosis and the temporal relation between atrophy and the clinical disease course have seldom been investigated. This study aims to determine the amount of infratentorial and supratentorial atrophy in patients by comparison with healthy controls, to establish the relation between atrophy and disability, and to derive the rates of volume loss in individual patients from their estimated disease durations.
METHODS: Three dimensional acquired MRI was performed on 20 relapsing-remitting and 20 secondary progressive multiple sclerosis patients and 10 control subjects. Volume data on infratentorial and supratentorial structures were obtained using the Cavalieri method of modern design stereology in combination with point counting. Corpus callosal sectional area and "T2 lesion load" were also determined.
RESULTS: Significantly reduced infratentorial and cerebral white matter volumes and corpus callosal sectional areas occurred in all patients compared with controls (p=0.0001-0.004). Mean estimates of volume loss in the cohort were -21%, -19%, -46%, and -12% for the brain stem, cerebellum, upper cervical cord and white matter, respectively, and -21% for the corpus callosal sectional area. Analysis of the amount of atrophy (volume differences between patients and controls) showed that upper cervical cord and cerebral white matter atrophy correlated with the expanded disability status scale (r=-0.37 and -0.37, p=0.018-0.023) and the Scripps neurologic rating scale scores (r=+0.49 and +0.43, p=0.002-0.007). There was no relation between estimated volume loss in the supratentorial and infratentorial compartments. The "T2 lesion load" was associated with ventricular enlargement and corpus callosal atrophy (r=+0.50 and -0.55, p=0.0003-0.0012). Infratentorial atrophy rates correlated with baseline exacerbation rates (r=-0.50 to -0.48, p=0.0016-0.0021) and were higher in relapsing-remitting than secondary progressive patients (p=0.009-0.02).
CONCLUSIONS: Significant cerebral and spinal cord volume reductions occurred in both patient subgroups compared with controls. Functional correlates were found with estimated volume loss in the upper cervical cord and cerebral white matter. Particularly for infratentorial structures, estimated rates of atrophy were higher in relapsing-remitting than secondary progressive patients, suggesting that atrophy, perhaps mainly due to tract degeneration, begins early in multiple sclerosis and may relate predominantly to acute inflammatory events, with or without other gradual non-inflammatory processes later in the disease course.

Entities:  

Mesh:

Year:  1999        PMID: 10084530      PMCID: PMC1736263          DOI: 10.1136/jnnp.66.3.323

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  52 in total

1.  Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

Authors:  D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; N Parker; S Kurth; S D Horn
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

2.  Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

Authors:  J W Thorpe; D Kidd; I F Moseley; B E Kenndall; A J Thompson; D G MacManus; W I McDonald; D H Miller
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

3.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis.

Authors:  D Kidd; J W Thorpe; B E Kendall; G J Barker; D H Miller; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

4.  Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.

Authors:  H Lassmann; G Suchanek; K Ozawa
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

Review 5.  Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.

Authors:  W I McDonald; D H Miller; A J Thompson
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

6.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

7.  Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.

Authors:  P M Matthews; E Pioro; S Narayanan; N De Stefano; L Fu; G Francis; J Antel; C Wolfson; D L Arnold
Journal:  Brain       Date:  1996-06       Impact factor: 13.501

8.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.

Authors:  N A Losseff; S L Webb; J I O'Riordan; R Page; L Wang; G J Barker; P S Tofts; W I McDonald; D H Miller; A J Thompson
Journal:  Brain       Date:  1996-06       Impact factor: 13.501

9.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.

Authors:  C A Davie; G J Barker; S Webb; P S Tofts; A J Thompson; A E Harding; W I McDonald; D H Miller
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

10.  Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

Authors:  M A van Walderveen; F Barkhof; O R Hommes; C H Polman; H Tobi; S T Frequin; J Valk
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

View more
  29 in total

1.  Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy.

Authors:  Carsten Lukas; Barbara Bellenberg; Horst K Hahn; Jan Rexilius; Robert Drescher; Kerstin Hellwig; Odo Köster; Sebastian Schimrigk
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

2.  Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development.

Authors:  Juha Martola; Leszek Stawiarz; Sten Fredrikson; Jan Hillert; Jakob Bergström; Olof Flodmark; Maria Kristoffersen Wiberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-21       Impact factor: 10.154

3.  Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis.

Authors:  Carsten Lukas; Horst K Hahn; Barbara Bellenberg; Jan Rexilius; Gebhard Schmid; Sebastian K Schimrigk; Horst Przuntek; Odo Köster; Heinz-Otto Peitgen
Journal:  Neuroradiology       Date:  2004-11-05       Impact factor: 2.804

Review 4.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

5.  Sulcal variability, stereological measurement and asymmetry of Broca's area on MR images.

Authors:  Simon Sean Keller; John Robin Highley; Marta Garcia-Finana; Vanessa Sluming; Roozbeh Rezaie; Neil Roberts
Journal:  J Anat       Date:  2007-08-29       Impact factor: 2.610

6.  Impact of very old age on the expression of cervical spinal cord cell markers in rats.

Authors:  Paula Andrea Fontana; Claudio Gustavo Barbeito; Rodolfo Gustavo Goya; Eduardo Juan Gimeno; Enrique Leo Portiansky
Journal:  J Chem Neuroanat       Date:  2008-11-19       Impact factor: 3.052

7.  Morphometric measurements of the cranium in congenital bilateral blind males and females.

Authors:  Rengin Kosif; Ocal Sirmatel; Arzu Canan
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

8.  Normalized regional brain atrophy measurements in multiple sclerosis.

Authors:  Robert Zivadinov; Laura Locatelli; Barbara Stival; Alessio Bratina; Attilio Grop; Davide Nasuelli; Ozana Brnabic-Razmilic; Marino Zorzon
Journal:  Neuroradiology       Date:  2003-10-10       Impact factor: 2.804

Review 9.  Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review.

Authors:  Blandine Grassiot; Béatrice Desgranges; Francis Eustache; Gilles Defer
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

10.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.